Term Name: | EC 3.1.1.5 (lysophospholipase) inhibitor |
---|---|
Synonyms: | 2-lysophosphatidylcholine acylhydrolase inhibitor, 2-lysophosphatidylcholine acylhydrolase inhibitors, EC 3.1.1.5 (lysophospholipase) inhibitors, EC 3.1.1.5 inhibitor, EC 3.1.1.5 inhibitors, lecithinase B inhibitor, lecithinase B inhibitors, lecitholipase inhibitor, lecitholipase inhibitors, lysolecithinase inhibitor, lysolecithinase inhibitors, lysophopholipase L2 inhibitor, lysophopholipase L2 inhibitors, lysophosphatidase inhibitor, lysophosphatidase inhibitors, lysophosphatidylcholine hydrolase inhibitor, lysophosphatidylcholine hydrolase inhibitors, lysophospholipase (EC 3.1.1.5) inhibitor, lysophospholipase (EC 3.1.1.5) inhibitors, lysophospholipase A1 inhibitor, lysophospholipase A1 inhibitors, lysophospholipase inhibitor, lysophospholipase inhibitors, lysophospholipase transacylase inhibitor, lysophospholipase transacylase inhibitors, neuropathy target esterase inhibitor, neuropathy target esterase inhibitors, NTE inhibitor, NTE inhibitors, NTE-lysophospholipase inhibitor, NTE-lysophospholipase inhibitors, NTE-LysoPLA inhibitor, NTE-LysoPLA inhibitors, phosphatidase B inhibitor, phosphatidase B inhibitors, phospholipase B inhibitor, phospholipase B inhibitors |
Definition: | An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of the enzyme lysophospholipase (EC 3.1.1.5), which catalyses the release of fatty acids from lysophospholipids. |
Ontology: | ChEBI [CHEBI:78372] ( EBI ) |